Sulphonamides Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Sulphonamides Market
1.1. Definition and Scope
1.1.1. Definition of Sulphonamides
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Sulphonamides Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Sulphonamides Market By Route of Administration
1.2.3. Sulphonamides Market By Application
1.2.4. Sulphonamides Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Sulphonamides Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Sulphonamides Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Sulphonamides Market By Route of Administration
5.1. Introduction
5.2. Sulphonamides Revenue By Route of Administration
5.2.1. Sulphonamides Revenue (USD Million) and Forecast, By Route of Administration, 2020-2032
5.2.2. Topical
5.2.2.1. Topical Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Oral
5.2.3.1. Oral Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Others
5.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Sulphonamides Market By Application
6.1. Introduction
6.2. Sulphonamides Revenue By Application
6.2.1. Sulphonamides Revenue (USD Million) and Forecast, By Application, 2020-2032
6.2.2. Skin Infections
6.2.2.1. Skin Infections Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Respiratory Tract Infection (RTI)
6.2.3.1. Respiratory Tract Infection (RTI)Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Urinary Tract Infection (UTI)
6.2.4.1. Urinary Tract Infection (UTI)Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Gastro Intestinal Tract (GIT) Infection
6.2.5.1. Gastro Intestinal Tract (GIT) InfectionMarket Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Sulphonamides Market By Country
7.1. North America Sulphonamides Market Overview
7.2. U.S.
7.2.1. U.S. Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
7.2.2. U.S. Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
7.3. Canada
7.3.1. Canada Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
7.3.2. Canada Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Sulphonamides Market By Country
8.1. Europe Sulphonamides Market Overview
8.2. U.K.
8.2.1. U.K. Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.2.2. U.K. Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
8.3. Germany
8.3.1. Germany Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.3.2. Germany Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
8.4. France
8.4.1. France Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.4.2. France Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
8.5. Spain
8.5.1. Spain Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.5.2. Spain Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.6.2. Rest of Europe Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Sulphonamides Market By Country
9.1. Asia Pacific Sulphonamides Market Overview
9.2. China
9.2.1. China Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.2.2. China Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
9.3. Japan
9.3.1. Japan Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.3.2. Japan Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
9.4. India
9.4.1. India Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.4.2. India Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
9.5. Australia
9.5.1. Australia Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.5.2. Australia Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
9.6. South Korea
9.6.1. South Korea Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.6.2. South Korea Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.7.2. Rest of Asia-Pacific Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Sulphonamides Market By Country
10.1. Latin America Sulphonamides Market Overview
10.2. Brazil
10.2.1. Brazil Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.2.2. Brazil Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
10.3. Mexico
10.3.1. Mexico Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.3.2. Mexico Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.4.2. Rest of Latin America Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Sulphonamides Market By Country
11.1. Middle East & Africa Sulphonamides Market Overview
11.2. GCC
11.2.1. GCC Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.2.2. GCC Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
11.3. South Africa
11.3.1. South Africa Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.3.2. South Africa Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Sulphonamides Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.4.2. Rest of Middle East & Africa Sulphonamides Revenue (USD Million) and Forecast By Application, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Sulphonamides Market
12.1. Sulphonamides Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Sulphonamides Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. F. Hoffmann-La Roche Ltd
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2022
13.1.3.2. F. Hoffmann-La Roche Ltd 2022 Sulphonamides Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. AA Pharma Inc.
13.3. GSK PLC
13.4. Abbott Laboratories
13.5. Akorn Operating Company LLC
13.6. Lexine Technochem Pvt. Ltd
13.7. Pfizer Inc.
13.8. Viatris Inc.
13.9. Amneal Pharmaceuticals LLC
13.10. Teva Pharmaceutical Industries Ltd
Frequently Asked Questions
How big is the sulphonamides market?
The sulphonamides market size was USD 119 Million in 2022.
What is the CAGR of the global Sulphonamides Market from 2023 to 2032?
The CAGR of sulphonamides is 4.7% during the analysis period of 2023 to 2032.
Which are the key players in the Sulphonamides Market?
The key players operating in the global market are including F. Hoffmann-La Roche Ltd, AA Pharma Inc., GSK PLC, Abbott Laboratories, Akorn Operating Company LLC, Lexine Technochem Pvt. Ltd, Pfizer Inc., Viatris Inc., Amneal Pharmaceuticals LLC, and Teva Pharmaceutical Industries Ltd.
Which region dominated the global Sulphonamides Market share?
North America held the dominating position in sulphonamides industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of sulphonamides during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global sulphonamides industry?
The current trends and dynamics in the Sulphonamides Market growth include rising incidence of bacterial infections worldwide, growing demand for combination antibiotic therapies, and increasing awareness of sulfonamide efficacy in treating specific infections.
Which route of administration held the maximum share in 2022?
The oral route of administration held the maximum share of the sulphonamides industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
